Trial reportMedicine2026
Clinical efficacy of acupuncture in the treatment of sciatica during the remission phase of lumbar disc herniation: A secondary analysis of a randomized controlled trial.
Trial report in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundSciatica caused by lumbar disc herniation (LDH) may persist during the remission phase and negatively affect patients' quality of life. Although acupuncture is widely used for LDH, evidence regarding its efficacy specifically in remission-phase sciatica remains limited. This prespecified subgroup analysis aimed to compare the efficacy and safety of acupuncture versus traction in participants with remission-phase LDH-induced sciatica.
methodsData were extracted from the acupuncture and traction groups of our multi-arm randomized controlled trial conducted at Wangjing Hospital between April 2022 and June 2024. We included participants with LDH-induced sciatica in the remission phase (VAS score ≥4 and <7). All participants received 3 weeks of treatment and were followed up for 16 weeks. The primary outcome was leg pain VAS (VAS-LP). Secondary outcomes included low back pain VAS (VAS-LBP), Oswestry Disability Index (ODI), and Japanese Orthopaedic Association (JOA) scores.
resultsA total of 78 eligible participants (39 in the acupuncture group, 39 in the traction group) were included. At week 3 and week 4 follow-up, VAS-LP scores were significantly lower in the acupuncture group, with between-group differences of -0.63 cm (P = .019) and -0.86 cm (P = .017), respectively. At week 16, the difference was -0.51 cm (P > .05). After 3 weeks, JOA scores and JOA improvement rates were significantly higher in the acupuncture group. The excellent rate was 67.57% in the acupuncture group versus 47.22% in the traction group (P = .041). No significant differences were observed in VAS-LBP or ODI scores. Adverse events occurred in 8.1% of participants in the acupuncture group and were mild and transient.
conclusionAcupuncture demonstrated superior short-term efficacy compared with traction in relieving leg pain during the remission phase of LDH and demonstrated a favorable safety profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.